Cargando…
Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid Leukemia
SIMPLE SUMMARY: Acute myeloid leukemia (AML) is a predominately fatal blood cancer. For a period of forty years, treatment options for AML remained relatively stagnant. Recently, multiple new agents have been approved. In this review, we discuss considerations surrounding the use of these newly appr...
Autores principales: | Ahmadmehrabi, Khashayar, Haque, Ali R., Aleem, Ahmed, Griffiths, Elizabeth A., Roloff, Gregory W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471378/ https://www.ncbi.nlm.nih.gov/pubmed/34572873 http://dx.doi.org/10.3390/cancers13184646 |
Ejemplares similares
-
Molecular landscape and targeted therapy of acute myeloid leukemia
por: Gu, Runxia, et al.
Publicado: (2018) -
The clinical impact of the molecular landscape of acute myeloid leukemia
por: Kayser, Sabine, et al.
Publicado: (2023) -
Molecularly Targeted Therapy in Acute Myeloid Leukemia: Current Treatment Landscape and Mechanisms of Response and Resistance
por: Lachowiez, Curtis A., et al.
Publicado: (2023) -
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
por: Marando, Ludovica, et al.
Publicado: (2020) -
The Epigenetic Landscape of Acute Myeloid Leukemia
por: Conway O'Brien, Emma, et al.
Publicado: (2014)